Bio-product

Bio-product refers to substances produced using biological entities or processes, including microbial, plant, or animal-based materials. According to ISO 56000 innovation management principles, Bio-product development requires integrating biotechnology, data science, and risk assessment. Unlike traditional industrial products, Bio-products possess living components, metabolic activities, and environmental interactions, necessitating bio-hazard assessment, GMO compliance (per the Cartagena Protocol), and biodiversity protection. Companies must establish a complete traceability system from lab to commercialization to ensure biological safety and regulatory compliance across different jurisdictions.

Bio-product risk management involves three critical steps. First, create a biological asset inventory, identifying risks associated with microbial strains, genetic data, and raw materials using ISO 31000 principles. Second, design a Bio-hazard Assessment process using FMEA (Failure Mode and Effects Analysis) to evaluate risks like cross-contamination or genetic drift. Third, implement supply chain resilience measures to ensure the biological safety of raw materials. For instance, a Taiwan-based biotech firm reduced raw material-related risks by 40% by implementing genetic fingerprinting for microbial strains, while increasing batch-to-batch compliance to 99.5% through automated monitoring systems.

Taiwan enterprises face three primary challenges: fragmented regulations (intersecting with the Biosafety Act, Food Safety Act, and Climate Change Response Act), a shortage of biotech-risk management professionals, and the need for robust IP protection for genetic data. To overcome these, companies should: 1) Establish a cross-functional regulatory compliance team; 2) Partner with academic institutions for talent development; 3) Implement information-secure management of genetic assets according to the Trade Secret Act. A phased approach—starting with a 30-day risk audit, followed by a 60-day ISO 31000 framework implementation, and ongoing 90-day cycles—is recommended for sustainable compliance and resilience.

Winners Consulting Services Co., Ltd. specializes in Bio-product-related risk management for Taiwan enterprises, delivering compliant management systems within 90 days. Our team has successfully assisted over 100 companies in navigating the complexities of biological risk-adjusted innovation. Request a free mechanism diagnosis: https://winners.com.tw/contact